Home > Products > B cell lymphoma 38C13 Idiotype & LFA-1 > Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (scFv-IgG)

Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (scFv-IgG)  (BSSG-014)

Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-B cell lymphoma 38C13 Idiotype antibody variable domain are respectively connected to the N terminus of the anti-LFA-1 IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy.

Specifications

Targets
B cell lymphoma 38C13 Idiotype & LFA-1
Type
Appended IgGs
Species Reactivity
Mouse
Target 1
B cell lymphoma 38C13 Idiotype
Host Animal 1
Rat
Target 2
LFA-1
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma

Targets

Target 1
B cell lymphoma 38C13 Idiotype
Alternative Names
B cell lymphoma 38C13 Idiotype; B cell lymphoma; 38C13; Idiotype; Id
Target 2
LFA-1
Gene ID
UniProt ID
Alternative Names
integrin subunit alpha L; Integrin beta chain-2; ITGB2; Integrin subunit beta 2; MF17, MAC-1; ITGAL; CD11A; LFA-1; LFA1A; ITGAL; CD18; LCAMB; AI528527; 2E6; LAD

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (scFv-IgG) (BSSG-014). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
See other bsAb targets related to "B cell lymphoma 38C13 Idiotype"

Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: